MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$30,911K
(-126.45%↓ Y/Y)
Interest income
$236K
(-61.69%↓ Y/Y)
Loss from operations
-$14,228K
(6.96%↑ Y/Y)
Other (income)
expense, net
-$12,546K
(-360.45%↓ Y/Y)
Interest expense
$4,373K
(15.38%↑ Y/Y)
Product revenue, net
$98K
(-54.21%↓ Y/Y)
Total operating
expenses
$14,326K
(-7.62%↓ Y/Y)
Research and development
$8,740K
(71.34%↑ Y/Y)
Selling, general and
administrative
$5,381K
(-29.96%↓ Y/Y)
Restructuring costs
$194K
(-87.51%↓ Y/Y)
Cost of goods sold
$11K
(-99.06%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. (BTAI)